pharmacare
Discussion and Debate
Commentary: Expedited Regulatory Review of Low-Value Drugs
Jonathan J. Darrow and Reed F. Beall
Research Paper
Developing a Canadian Real-World Evidence Action Plan across the Drug Life Cycle
Mina Tadrous, Tarry Ahuja, Basanti Ghosh and Rhonda Kropp
Research Paper
Ten Years of Inaction on Antimicrobial Resistance: An Environmental Scan of Policies in Canada from 2008 to 2018
Susan Rogers Van Katwyk, Jeremy M. Grimshaw and Steven J. Hoffman
CIHI Survey
Prescribed Drug Spending in Canada, 2019: A Focus on Public Drug Program
Kathy Lee, Trupti Jani, Roger Cheng and Jordan Hunt
Patient Safety
Adverse Drug Reactions in Canada (2009–2018): Insights from the Canada Vigilance Database
Tuhin S. Maity and Christopher J. Longo
Research Papers
An Exploratory Analysis of Predictors of Concordance Between Canadian Common Drug Review Reimbursement Recommendations and the Subsequent Decisions by Ontario, British Columbia and Alberta
Michael J. Zoratti, Feng Xie, Kristian Thorlund, Nicola Allen and Mitchell Levine
Research Paper
Policies for Deprescribing: An International Scan of Intended and Unintended Outcomes of Limiting Sedative-Hypnotic Use in Community-Dwelling Older Adults
James Shaw, Andrea L. Murphy, Justin P. Turner, David M. Gardner, James L. Silvius, Zachary Bouck, D...
Discussion and Debate
Increase in Drug Spending in Canada Due to Extension of Data Protection for Biologics: A Descriptive Study
Joel Lexchin